Wednesday, July 6, 2022

SARS-CoV-2

Differentiating antibody targets using Machine Learning Model

The new approach successfully differentiates between antibodies against influenza and those attacking SARS-CoV-2, the virus that causes COVID-19.

Some patients with long COVID have lasting nerve damage

Almost all post-COVID neuropathy is linked to a potentially treatable immune dysfunction.

Booster dose is essential to provide immunity against the Omicron

No Omicron immunity without a booster.

Study to find why bats live with viruses but don’t get sick

The knowledge could help us to reduce the threat to humans of infectious diseases.

Scientists identified antibodies that neutralize omicron

Findings could lead to the development of more effective vaccines and antibody treatments.

Sensor-based on quantum physics could detect the SARS-CoV-2 virus

Mathematical simulations show the new approach may offer faster, cheaper, and more accurate detection.

Why are some COVID cases more severe?

'Humanized' mice offer a clue.

A fusion protein acts as a promising medication against SARS-CoV-2

The new strategy also promises protection against future SARS-CoV-2 variants.

Why are infants less affected by COVID than adults

Infant Immune Systems are stronger than you think

Why does COVID-19 strike Asthma Sufferers less severely

Having asthma confers some degree of protection against COVID-19.

Infection Plus Vaccination for improved defense against COVID-19

Infection plus vaccination yields better antibodies against COVID-19 variants

A chewing gum that could reduce SARS-CoV-2 transmission

It could be given to patients whose infection status is unknown or even for a dental check-up when masks need to be removed to reduce the likelihood of passing the virus to caregivers.

Recent Stories